Ohio Board of Pharmacy Publishes Guidance Documents for Recent Law and Rule Changes

The Ohio Board of Pharmacy has recently published a number of guidance documents regarding recent law and rule changes that may pertain to our AMCNO members. They include the following:

  • TDDD Requirements for Controlled Substances: All locations that possess controlled substances are required to obtain licensure as a category III terminal distributor of dangerous drugs. Please be aware that this requirement takes effect on April 6, 2017. More information on the provision can be found by visiting www.pharmacy.ohio.gov/TDDDcs.

 

  • Office-Based Opioid Treatment: Effective August 4, 2017, all locations that treat more than 30 individuals for opioid dependence or addiction using a controlled substance are required to obtain a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. Please be aware that there are some exemptions to this requirement. More information on the provision can be found by visiting www.pharmacy.ohio.gov/OBOT.

 

  • Effective April 1, 2017, all prescribers that possess compounded drugs or engage in the compounding of dangerous drugs (ie, prescription drugs) must obtain a license as a terminal distributor of dangerous drugs (ORC 4729.541). More information on the provision can be found at www.pharmacy.ohio.gov/prescribercompound.


The Pollen Line is now closed. See you in the spring!

Grass: 0
Mold: 0

Weed: 0

Tree: 0

Ragweed: 0

AMCNO on Twitter